Maxcyte (MXCT) EBIT Margin Growth (3y) (2023 - 2026)
Maxcyte (MXCT) EBIT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,016.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -3,846.00 |
| 10 | Maxcyte | 127.72 Mn | 127.72 Mn | 8.08 Mn | 20,138.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,138.00 |
| Dec 31, 2025 | -87,478.00 |
| Sep 30, 2025 | -9,936.00 |
| Jun 30, 2025 | -15,333.00 |
| Mar 31, 2025 | -17,819.00 |
| Dec 31, 2024 | 11,353.00 |
| Sep 30, 2024 | -12,858.00 |
| Jun 30, 2024 | -17,895.00 |
| Mar 31, 2024 | -6,948.00 |
| Dec 31, 2023 | 11,087.00 |
| Sep 30, 2023 | -27,483.00 |
| Jun 30, 2023 | -2,228.00 |